| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.062 | 0.2 |